The expression of the farnesoid X receptor (FXR), for which BAs are endogenous ligands [37,38,39,40], also influenced the Wnt/β-catenin signaling pathway and correlated inversely with the CRC stage and the clinical outcome [129]. This evidence concerns the gene NR1H4 and colorectal carcinoma.